Vitamins C and K3 Sensitize Human Urothelial Tumors to Gemcitabine
is companion of
Abstract
Purpose:
We evaluated the antitumor effects of vitamins C and K3 for human urothelial carcinoma and the potential use of the combination of vitamins C plus K3 as a sensitizing agent for conventional chemotherapy for urothelial carcinoma.
Materials and Methods:
The antiproliferative and apoptotic effects of vitamin C alone, vitamin K3 alone, vitamins C plus K3, gemcitabine alone and gemcitabine plus vitamins C plus K3 were assessed in vitro by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay, propidium iodide staining and flow cytometry. For in vivo studies we implanted UMUC-14 tumorigenic urothelial carcinoma cells into the subcutis of nude mice. One week later we treated 10 mice each with saline (control), vitamins C plus K3, gemcitabine or gemcitabine plus vitamins C plus K3. Treatment was continued for 4 weeks, followed by necropsy. Tumor volume was measured and tumor kinetics were established. Apoptosis and proliferation were evaluated in tumor sections using immunohistochemistry and TUNEL assay.
Results:
Vitamins C plus K3 induced cytostasis and caused apoptosis to a greater degree than either vitamin alone (p <0.05). Vitamins C plus K3 also substantially augmented the effects of gemcitabine in vitro. There were 32.3% apoptosis with gemcitabine plus vitamins C plus K3, 5.3% with gemcitabine alone and 15.8% with vitamins C plus K3 alone (p <0.05). In vivo tumor growth was substantially inhibited by gemcitabine plus vitamins C plus K3 compared with that in the control or for either agent alone. Mean tumor weight and growth rate in the gemcitabine plus vitamins C plus K3 group (237 mg and 11.3 mm3 daily) were decreased compared with those in the control (530 mg and 34.3 mm3 daily), and those for vitamins C plus K3 alone (490 mg and 25.2 mm3 daily) and gemcitabine alone (400 mg and 21.3 mm3 daily) (p <0.05).
Conclusions:
Vitamins C and K3 have significant antiproliferative and apoptotic effects when used in combination. This combination enhances the efficacy of gemcitabine against bladder cancer in vivo.
References
- 1 : Cancer statistics, 2004. CA Cancer J Clin2004; 54: 8. Google Scholar
- 2 : Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse. Cancer1989; 64: 2448. Google Scholar
- 3 : Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol2000; 18: 3068. Google Scholar
- 4 : Combination paclitaxel, carboplatin, and gemcitabine is an active treatment for advanced urothelial cancer. J Clin Oncol2001; 19: 2527. Google Scholar
- 5 : Current trends in bladder cancer treatment. Ann Chir Gynaecol2000; 89: 234. Google Scholar
- 6 : Chemoprevention of bladder cancer. Cancer1987; 60: 650. Google Scholar
- 7 : Megadose vitamins in bladder cancer: a double-blind clinical trial. J Urol1994; 151: 21. Link, Google Scholar
- 8 : Increase in nuclease activity as a possible means for detecting tumor cell sensitivity to anticancer agents. Cancer1981; 47: 523. Google Scholar
- 9 : Vitamin C inhibits NF-kappa B activation by TNF via the activation of p38 mitogen-activated protein kinase. J Immunol2000; 165: 7180. Google Scholar
- 10 : The association of vitamins C and K3 kills cancer cells mainly by autoschizis, a novel form of cell death. Basis for their potential use as coadjuvants in anticancer therapy. Eur J Med Chem2003; 38: 451. Google Scholar
- 11 : Uncoupling between epidermal growth factor receptor and downstream signals defines resistance to the antiproliferative effect of gefitinib in bladder cancer cells. Cancer Res2005; 65: 10524. Google Scholar
- 12 : Effect of soybean feeding on experimental carcinogenesis–III. Carcinogenecity of nitrite and dibutylamine in mice: a histopathological study. Eur J Cancer Clin Oncol1988; 24: 403. Google Scholar
- 13 : Ascorbate-nitrite reaction: possible means of blocking the formation of carcinogenic N-nitroso compounds. Science1972; 177: 65. Google Scholar
- 14 : Cytotoxic effect of ascorbate and its derivatives on cultured malignant and nonmalignant cell lines. Anticancer Res1993; 13: 475. Google Scholar
- 15 : Vitamin C preferential toxicity for malignant melanoma cells. Nature1980; 284: 629. Google Scholar
- 16 : Menadione: spectrum of anticancer activity and effects on nucleotide metabolism in human neoplastic cell lines. Biochem Pharmacol1991; 41: 1283. Google Scholar
- 17 : Comparison of antitumor activity of vitamins K1, K2 and K3 on human tumor cells by two (MTT and SRB) cell viability assays. Life Sci1993; 52: 1797. Google Scholar
- 18 : Growth inhibition of hepatoma cells induced by vitamin K and its analogs. J Biol Chem1995; 270: 28304. Google Scholar
- 19 : Effects of sodium ascorbate (vitamin C) and 2-methyl-1,4-naphthoquinone (vitamin K3) treatment on human tumor cell growth in vitro. I. Synergism of combined vitamin C and K3 action. Cancer1989; 63: 901. Google Scholar
- 20 : Autoschizis: a novel cell death. Biochem Pharmacol2002; 63: 1773. Google Scholar
